A machine learning approach to predict the glaucoma filtration surgery outcome.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
24 10 2023
24 10 2023
Historique:
received:
14
07
2023
accepted:
11
10
2023
medline:
27
10
2023
pubmed:
25
10
2023
entrez:
24
10
2023
Statut:
epublish
Résumé
This study aimed at predicting the filtration surgery (FS) outcome using a machine learning (ML) approach. 102 glaucomatous patients undergoing FS were enrolled and underwent ocular surface clinical tests (OSCTs), determination of surgical site-related biometric parameters (SSPs) and conjunctival vascularization. Break-up-time, Schirmer test I, corneal fluorescein staining, Meibomian gland expressibility; conjunctival hyperemia, upper bulbar conjunctiva area of exposure, limbus to superior eyelid distance; and conjunctival epithelial and stromal (CET, CST) thickness and reflectivity (ECR, SCR) at AS-OCT were considered. Successful FS required a 30% baseline intraocular pressure reduction, with values ≤ 18 mmHg with or without medications. The classification tree (CT) was the ML algorithm used to analyze data. At the twelfth month, FS was successful in 60.8% of cases, whereas failed in 39.2%. At the variable importance ranking, CST and SCR were the predictors with the greater relative importance to the CART tree construction, followed by age. CET and ECR showed less relative importance, whereas OSCTs and SSPs were not important features. Within the CT, CST turned out the most important variable for discriminating success from failure, followed by SCR and age, with cut-off values of 75 µm, 169 on gray scale, and 62 years, respectively. The ROC curve for the classifier showed an AUC of 0.784 (0.692-0.860). In this ML approach, CT analysis found that conjunctival stroma thickness and reflectivity, along with age, can predict the FS outcome with good accuracy. A pre-operative thick and hyper-reflective stroma, and a younger age increase the risk of FS failure.
Identifiants
pubmed: 37875579
doi: 10.1038/s41598-023-44659-6
pii: 10.1038/s41598-023-44659-6
pmc: PMC10598019
doi:
Substances chimiques
Fluorescein
TPY09G7XIR
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
18157Informations de copyright
© 2023. Springer Nature Limited.
Références
Am J Ophthalmol. 2006 Apr;141(4):652-9
pubmed: 16564799
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO114-BIO120
pubmed: 28586797
Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7787-91
pubmed: 21873655
Graefes Arch Clin Exp Ophthalmol. 1995 Mar;233(3):154-62
pubmed: 7758983
Invest Ophthalmol Vis Sci. 2011 Nov 25;52(12):9116-23
pubmed: 22025572
Clin Exp Ophthalmol. 2020 Dec;48(9):1192-1200
pubmed: 32918375
Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):1930-7
pubmed: 21450914
Sci Rep. 2022 Feb 15;12(1):2473
pubmed: 35169235
Cornea. 2003 Oct;22(7):640-50
pubmed: 14508260
Invest Ophthalmol Vis Sci. 2013 Jul 12;54(7):4705-9
pubmed: 23744999
J Clin Med. 2022 Jul 07;11(14):
pubmed: 35887722
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Sci Rep. 2016 Feb 09;6:21161
pubmed: 26856372
World J Surg. 2022 Dec;46(12):3100-3110
pubmed: 36109367
J Glaucoma. 2006 Feb;15(1):40-6
pubmed: 16378017
Arch Ophthalmol. 1994 Nov;112(11):1446-54
pubmed: 7980134
Acta Ophthalmol. 2022 Nov;100(7):740-751
pubmed: 35088941
Ophthalmology. 2012 Apr;119(4):694-702
pubmed: 22196977
PLoS One. 2009 Nov 25;4(11):e8022
pubmed: 19946627
J Am Optom Assoc. 1987 Mar;58(3):198-201
pubmed: 3571821
Ocul Surf. 2017 Jul;15(3):539-574
pubmed: 28736342
Emerg Themes Epidemiol. 2017 Sep 20;14:11
pubmed: 28943885
Am J Ophthalmol. 2019 Dec;208:30-40
pubmed: 31323204
J Healthc Eng. 2022 Sep 10;2022:2863495
pubmed: 36124238
J Ocul Pharmacol Ther. 2019 May;35(4):216-222
pubmed: 30758244
Am J Sports Med. 2022 Nov;50(13):3593-3599
pubmed: 36135373